☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
metastatic non-squamous non-small cell lung cancer
Roche's Tecentriq + CT (abraxane and carboplatin) Receive the US FDA's Approval for the Initial Treatment of Metastatic Non-Squamo...
December 4, 2019
Roche's Tecentriq (atezolizumab) Combination Therapy Receives Health Canada's Approval for Metastatic Non-Squamous Non-Small Cell...
May 30, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.